A Brief Review on Gestational Diabetes: Insights into Current Understanding and Future Perspectives
Keywords:
Gestational Diabetes Mellitus, Obesity, Glucose metabolism, Insulin, NormoglycemiaAbstract
The term "Gestational Diabetes Mellitus" (GDM) is the term used to describe different levels of glucose intolerance that were first discovered during pregnancy. About 2-10% women worldwide experience Gestational Diabetes. In order to identify GDM, pregnant women are screened for clinical risk factors and at risk women are tested for impaired glucose tolerance, which is typically, but not always, mild and asymptomatic. The wide range of physiological and genetic problems that define diabetes outside of pregnancy also seem to be the cause of GDM. It is true that women with GDM have a higher chance of getting diabetes outside of pregnancy. As a result, GDM offers a rare chance to research the early causes of diabetes and create preventative measures. Obesity, impaired glucose metabolism, and cardiovascular disease are among the long-term concerns that GDM raises the risk of for both the mother and the kid. In most parts of the world, preventive measures are not widely used, making it difficult to treat mothers and infants optimally during long-term follow-up.The main treatments for GDM include dietary changes and increased exercise, but when normoglycemia cannot be reached, medication typically insulin is utilized.
References
[1] E. U. Alejandro et al., “Gestational diabetes mellitus: A harbinger of the vicious cycle of diabetes,” Int. J. Mol. Sci., vol. 21, no. 14, p. 5003, 2020, doi: 10.3390/ijms21145003.
[2] H. D. McIntyre et al., “Gestational diabetes mellitus,” Nat. Rev. Dis. Primers, vol. 5, no. 1, p. 47, 2019, doi: 10.1038/s41572-019-0098-8.
[3] R. Modzelewski et al., “Gestational diabetes mellitus—Recent literature review,” J. Clin. Med., vol. 11, no. 19, p. 5736, 2022, doi: 10.3390/jcm11195736.
[4] F. Kiani, S. Shahsavari, and Z. Saeedizadeh, “The risk factors of gestational diabetes mellitus: A systematic review and meta-analysis study,” Diabetes, vol. 10, p. 17, 2017.
[5] F. N. Amiri et al., “Risk factors for gestational diabetes mellitus: A case-control study,” Am. J. Lifestyle Med., vol. 15, no. 2, pp. 184–190, 2018, doi: 10.1177/1559827618791980.
[6] A. Ben-Haroush, Y. Yogev, and M. Hod, “Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes,” Diabet. Med., vol. 21, no. 2, pp. 103–113, 2004, doi: 10.1111/j.1464-5491.2004.01030.x.
[7] Mayo Clinic Staff, “Gestational diabetes,” 2023. [Online]. Available: https://www.mayoclinic.org/diseases-conditions/gestational-diabetes
[8] Z. Villines, “Gestational diabetes: Causes, risks, and treatment,” Medical News Today, 2019. [Online]. Available: https://www.medicalnewstoday.com/articles/325177.
[9] P. R. Rani and J. Begum, “Screening and diagnosis of gestational diabetes mellitus: Where do we stand?” J. Clin. Diagn. Res., vol. 10, no. 4, pp. QE01–QE04, 2016, doi: 10.7860/JCDR/2016/17588.7689.
[10] A. Sakhamuru and S. Vasireddy, “AI-Enabled Cross-Layer QoS Routing Framework for Mission-Critical 5G/6G-Integrated MANETs and UAV Swarms,” 2025 International Conference on Sustainable Communication Networks and Application (ICSCN), pp. 787–794, Oct. 2025, doi: 10.1109/icscn67106.2025.11308381.
[11] L. Hartling et al., Screening and diagnosing gestational diabetes mellitus, AHRQ, 2012. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK114844/
[12] V. Seshiah et al., “One step procedure for screening and diagnosis of gestational diabetes mellitus,” Diabetes Res. Clin. Pract., vol. 126, p. 200, 2005.
[13] Abhishake Reddy Onteddu, Rahul Reddy Bandhela and RamMohan Reddy Kundavaram, “Enhancing E-Commerce Product Recommendations through Data Engineering and Machine Learning,” Economic Sciences, vol. 20, no. 1, pp. 171–183, Mar. 2024, doi: 10.69889/vqgzw857.
[14] S. Schneider et al., “Neonatal complications and risk factors among women with gestational diabetes mellitus,” Acta Obstet. Gynecol. Scand., vol. 90, no. 3, pp. 231–237, 2011, doi: 10.1111/j.1600-0412.2010.01040.x.
[15] M. Andrews, “Gestational diabetes complications,” Healthline, 2023. [Online]. Available: https://www.healthline.com
[16] A. M. Egan and F. P. Dunne, “Optimal management of gestational diabetes,” Br. Med. Bull., vol. 131, no. 1, pp. 97–108, 2019, doi: 10.1093/bmb/ldz014.
[17] A. Sakhamuru and S. Vasireddy, “A comprehensive review of state-of-the-art generative AI models in natural language processing: Architectures, innovations, applications, and future directions,” Frontiers in Health Informatics, vol. 13, no. 3, pp. 9498–9506, 2024.
[18] D. Farrar et al., “Treatments for gestational diabetes: A systematic review and meta-analysis,” BMJ Open, vol. 7, no. 6, e015557, 2017, doi: 10.1136/bmjopen-2016-015557.
[19] E. C. Johns et al., “Gestational diabetes mellitus: Mechanisms, treatment, and complications,” Trends Endocrinol. Metab., vol. 29, no. 11, pp. 743–754, 2018, doi: 10.1016/j.tem.2018.09.006.
[20] Animalia Life, “Gestational diabetes treatment,” [Online]. Available: https://www.animalia-life.club
[21] Rahul Reddy Bandhela, Abhishake Reddy Onteddu, RamMohan Reddy Kundavaram, “Enhancing Precision Healthcare Machine Learning For Advanced Diagnostics And Personalized Treatment”, SEEJPH, Jul. 2022.
[22] eMediHealth, “How to manage gestational diabetes,” [Online]. Available: https://www.emedihealth.com
[23] Circufiber, “Gestational diabetes diet,” [Online]. Available: https://www.circufiber.com
[24] K. Benhalima, “Recent advances in gestational diabetes mellitus,” J. Clin. Med., vol. 10, no. 10, p. 2202, 2021, doi: 10.3390/jcm10102202.
[25] Abhishake Reddy Onteddu, “AI and Deep Learning-Based Intelligent Drug Recommendation System for Patient Health Monitoring in IoT-Enabled Healthcare”, jier, vol. 1, no. 3, Dec. 2021.
[26] Z. J. Gu et al., “New approaches in diagnosis and prognosis of gestational diabetes mellitus,” Eur. Rev. Med. Pharmacol. Sci., vol. 27, no. 21, 2023.
[27] SheCares, “Gestational diabetes,” [Online]. Available: https://www.shecares.com
[28] C. J. Petry, “Gestational diabetes: Risk factors and recent advances,” Br. J. Nutr., vol. 104, no. 6, pp. 775–787, 2010, doi: 10.1017/S0007114510001741.
[29] Srinivasarao Goda, Pratap Pachipulusu, Sakhamuru Amulya, and Pathan Hussian Basha, “Secure Blockchain-Based Consumer Electronics Platform for Smart Homes with Efficient Access Control and Performance Evaluation”, Synth. Multidiscip. Res. J., vol. 3, no. 4, pp. 54–65, Dec. 2025
[30] E. Guarino et al., “Circulating microRNAs as biomarkers of gestational diabetes mellitus,” Int. J. Endocrinol., vol. 2018, p. 6380463, 2018, doi: 10.1155/2018/6380463.
[31] H. Rathnayake et al., “Advancement in predictive biomarkers for gestational diabetes mellitus,” BMJ Open, vol. 14, no. 12, e089937, 2024, doi: 10.1136/bmjopen-2023-089937
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles in this journal are licensed under the Creative Commons Attribution-NonCommercial 4.0 International License. This license permits others to copy, distribute, and adapt the work, provided it is for non-commercial purposes, and the original author and source are properly credited.
